J. Shah

发表

Preformulation study of etoposide: II. Increased solubility and dissolution rate by solid-solid dispersions

Diana Chow, Jaymin C. Shah, Jivn R. Chen, 1995 .

Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone.

Jaymin C Shah, Jinyang Hong, Maura D Mcgonagle, 2011, Journal of pharmaceutical sciences.

Pharmacokinetics of oxytetracycline in the white shrimp, Litopenaeus setiferus

T. Siewicki, J. Shah, L. Reed, 2004 .

Degradable polymers for site-specific drug delivery

A. Domb, S. Amselem, M. Maniar, 1992 .

Analysis of percutaneous permeation data: II. Evaluation of the lag time method

S. Lau, S. Tenjarla, J. Shah, 1994 .

Analysis of permeation data: evaluation of the lag time method

J. Shah, 1993 .

A New Vision for the Eye: Unmet Ocular Drug Delivery Needs

S. Mittal, Siladitya Ray Chaudhuri, J. Shah, 2015, Pharmaceutical Research.

Pharmacokinetics of DUR-928 in alcoholic hepatitis patients - a phase 2a study

Weiqi Lin, J. Shah, Christine Blevins, 2020, Journal of Hepatology.

Application of kinetic model to in vitro percutaneous permeation of drugs

J. Shah, 1996 .

Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.

K. Wesnes, J. Shah, H. Henney, 2006, Clinical therapeutics.

Controlled Release — Small Molecules

J. Shah, 2007 .

Development of an Implantable, Biodegradable, Controlled Drug Delivery System for Local Antibiotic Therapy

S. Bogdansky, J. Shah, S. Allababidi, 1994 .

pH-Dependent solubility and dissolution of bupivacaine and its relevance to the formulation of a controlled release system

M. Maniar, J. Shah, 1993 .

Controlled release of a local anesthetic from fatty acid dimer based polyanhydride

A. Domb, M. Maniar, J. Shah, 1994 .

Tenofovir Disoproxil Fumarate

B. Kearney, J. Flaherty, J. Shah, 2004, Clinical pharmacokinetics.

Tenofovir Disoproxil Fumarate

B. Kearney, J. Flaherty, J. Shah, 2021, Reactions Weekly.

Lack of Pharmacokinetic Drug Interaction between Tenofovir Disoproxil Fumarate and Nelfinavir Mesylate

M. Boffito, A. Mathias, B. Kearney, 2005, Antimicrobial Agents and Chemotherapy.

Crystallization and Rheology of Mono- and Diglycerides and Their Role in Stabilization of Emulsion Droplets in Model Topical Ointments.

J. Seth, P. Doshi, J. Shah, 2022, Langmuir : the ACS journal of surfaces and colloids.

Hydrolysis in Pharmaceutical Formulations

Franco Lombardo, Karen M. Alsante, Karen M Alsante, 2002, Pharmaceutical development and technology.

Efficacy and Pharmacokinetics of Site-Specific Cefazolin Delivery Using Biodegradable Implants in the Prevention of Post-operative Wound Infections

J. Shah, S. Allababidi, Saleh Allababidi, 1998, Pharmaceutical Research.

The biopharmaceutics and oral bioavailability of two forms of oxytetracycline to the white shrimp, Litopenaeus setiferus☆

T. Siewicki, J. Shah, L. Reed, 2006 .

Systemic and Renal Pharmacokinetics of Adefovir and Tenofovir Upon Coadministration

Ramin Ebrahimi, R. Ebrahimi, B. Kearney, 2005, Journal of clinical pharmacology.

Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients

D. Bergen, W. Rosenfeld, R. Levy, 2004, Epilepsy Research.

API-Polymer Interactions in Sepineo P600 based Topical Gel Formulation- Impact on Rheology.

J. Shah, Thean Yeoh, Abu Zayed Md Badruddoza, 2022, International journal of pharmaceutics.

Percutaneous permeation of the meta, ortho and para isomers of N,N-diethyltoluamide

J. Shah, J. Stinecipher, Julie Stinecipher, 1998 .

Influence of dosage form on the intravitreal pharmacokinetics of diclofenac.

U. Kompella, H. Edelhauser, J. Shah, 2009, Investigative ophthalmology & visual science.

Prediction of Vitreal Half-Life Based on Drug Physicochemical Properties: Quantitative Structure–Pharmacokinetic Relationships (QSPKR)

Uday B. Kompella, U. Kompella, Chandrasekar Durairaj, 2009, Pharmaceutical Research.

Effects of model compounds with varying physicochemical properties on erosion of polyanhydride devices

E. Park, M. Maniar, J. Shah, 1996 .

Analysis of Codeine and its Metabolites in Human Plasma by HPLC with Electrochemical Detection

W. D. Mason, J. Shah, 1987 .

Method for Determination of Codeine and Morphine in Rat Whole Blood by High Pressure Liquid Chromatography

W. D. Mason, J. Shah, 1987 .

Lack of Clinically Significant Pharmacokinetic Interactions Between Zonisamide and Lamotrigine at Steady State in Patients With Epilepsy

M. Brodie, R. Levy, I. Ragueneau-Majlessi, 2005, Therapeutic drug monitoring.

Lack of Pharmacokinetic Interactions Between Steady-State Zonisamide and Valproic Acid in Patients with Epilepsy

M. Brodie, R. Levy, I. Ragueneau-Majlessi, 2005, Clinical pharmacokinetics.

Delineating the role of cooperativity in the design of potent PROTACs for BTK

Graham M. West, James Smith, V. Shanmugasundaram, 2018, Proceedings of the National Academy of Sciences.

Preformulation Study of Etoposide: Identification of Physicochemical Characteristics Responsible for the Low and Erratic Oral Bioavailability of Etoposide

Jivn R. Chen, J. Shah, D. Chow, 1989, Pharmaceutical Research.

Local Delivery of Vancomycin for the Prophylaxis of Prosthetic Device-Related Infections

J. Shah, D. Chilukuri, 2005, Pharmaceutical Research.

Oral bioavailability and in situ absorption of etoposide in rat

Jivn R. Chen, J. Shah, D. Chow, 1992 .

Model for Long Acting Injectables (Depot Formulation) Based on Pharmacokinetics and Physical Chemical Properties

J. Shah, Jinyang Hong, 2022, The AAPS Journal.

Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release.

J C Shah, E. Park, M. Maniar, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Polyanhydrides: Synthesis and characterization

A. Domb, S. Amselem, M. Maniar, 1993 .

Multiple‐Dose Pharmacokinetics and Pharmacodynamics of OROS and Immediate‐Release Amitriptyline Hydrochloride Formulations

Suneel K. Gupta, Stephen S. Hwang, J. Shah, 1998, Journal of clinical pharmacology.

Assessing and Predicting Physical Stability of Emulsion-Based Topical Semisolid Products: A Review.

A. Z. Badruddoza, J. Shah, Thean Yeoh, 2023, Journal of pharmaceutical sciences.

Semisolid Pharmaceutical Product Characterization Using Non-invasive X-ray Microscopy and AI-Based Image Analytics

A. Z. Badruddoza, Shawn X. Zhang, J. Shah, 2022, The AAPS Journal.

Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.

J. Shah, H. Henney, 2007, Clinical therapeutics.

In Vitro Dissolution Versus In Vivo Evaluation of Four Different Aspirin Products

D. Ellis, B. Molony, J. Shah, 1994 .

In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations.

A. Thombre, K. Sagawa, Avinash G Thombre, 2012, International journal of pharmaceutics.

A dose-ranging study of the pharmacokinetics of codeine phosphate following intravenous administration to rats.

W. D. Mason, J. Shah, 1991, Journal of pharmaceutical sciences.

A New Vision for the Eye: Unmet Ocular Drug Delivery Needs

S. Mittal, Siladitya Ray Chaudhuri, J. Shah, 2015, Pharmaceutical Research.

Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment

B. Kearney, Lijie Zhong, J. Flaherty, 2006, Clinical pharmacokinetics.

Water uptake in to polyanhydride devices: kinetics of uptake and effects of model compounds incorporated, and device geometry on water uptake

E. Park, M. Maniar, J. Shah, 1996 .

Selective complexing agents designed after adenosine receptor as percutaneous permeation enhancers of drugs

J. Shah, V. R. Uppoor, 1996 .

Lack of a Clinically Significant Effect of Zonisamide on Phenytoin Steady‐State Pharmacokinetics in Patients With Epilepsy

W. Rosenfeld, R. Levy, I. Ragueneau-Majlessi, 2004, Journal of clinical pharmacology.

Reduction in skin permeation of N,N-diethyl-m-toluamide (DEET) by altering the skin/vehicle partition coefficient.

J. Shah, Julie Ross, J. Shah, 2000, Journal of controlled release : official journal of the Controlled Release Society.

Evaluation of cannabidiol nanoparticles and nanoemulsion biodistribution in the central nervous system after intrathecal administration for the treatment of pain.

P. Gershkovich, S. Woodhams, V. Chapman, 2023, Nanomedicine : nanotechnology, biology, and medicine.

Cubic phase gels as drug delivery systems.

D M Chilukuri, J C Shah, Y Sadhale, 2001, Advanced drug delivery reviews.

Pharmacokinetic and pharmacodynamic characterization of OROS and immediate-release amitriptyline.

Suneel K. Gupta, Stephen S. Hwang, S. Gupta, 1999, British journal of clinical pharmacology.

Plasma Codeine and Morphine Concentrations After a Single Oral Dose of Codeine Phosphate

W. D. Mason, J. Shah, 1990, Journal of clinical pharmacology.

Influence of physicochemical properties of model compounds on their release from biodegradable polyanhydride devices

E. Park, M. Maniar, J. Shah, 1997 .

Development and Preclinical PK / PD Evaluations of Diethylstilbestrol Nanosuspensions in Rats

S. Tu, T. Samant, J. Shah, 2013 .

Feasibility and Functionality of OROS® Melatonin in Healthy Subjects

Suneel K. Gupta, J. Shah, V. Langmuir, 1999, Journal of clinical pharmacology.